ライフサイエンスコーパス: platelet-derived

1 activation of the receptor tyrosine kinases, platelet-derived and epidermal growth factor receptors.

2 gery, cases had 2- and 4-fold more activated platelet-derived and tissue-factor positive MVs respecti

3 Tie-2 agonist and its source, we found that platelet-derived angiopoietin-1 (Angpt1) was required to

4 immunity: conferring intrinsic resistance to platelet-derived antimicrobial components and inhibiting

5 The platelet-derived CD61-positive EVs and CD9-positive EVs,

6 ue-coinfected patients, plasma levels of the platelet-derived chemokines RANTES/CCL5 and PF4/CXCL4 we

7 Therefore, platelet-derived disulfide HMGB1 is a central mediator o

8 The plasma platelet-derived exosome number is lower and its chemoki

9 endothelial cell-derived exosomes (EDEs) and platelet-derived exosomes (PDEs) were precipitated and e

10 A new method for isolation of plasma platelet-derived exosomes is described and used to exami

11 Cargo proteins of human plasma platelet-derived exosomes may biomark platelet abnormali

12 Platelet-derived exosomes mediate platelet atherogenic i

13 ly suppressed cargo protein levels of plasma platelet-derived exosomes without altering total levels

14 Plasma platelet-derived exosomes, enriched by absorption with m

15 Human plasma platelet-derived exosomes: effects of aspirin.

16 Platelet-derived extracellular vesicles (PDEVs) are the

17 Moreover, platelet factor 4 levels and platelet-derived extracellular vesicles were increased i

18 Platelet derived-extracellular vesicles (PEVs) are small

19 individual completely devoid of plasma- and platelet-derived factor V (FV) identified 167 variants i

20 Through these interactions, platelet-derived factors can contribute to the proinflam

21 The postoperative profile of circulating platelet-derived factors correlates with the ability of

22 A morphologic analysis of platelets derived from three affected individuals was pe

23 s individual, its effects on his plasma- and platelet-derived FV concentrations were assessed.

24 hat in an individual with normal plasma- and platelet-derived FV concentrations.

25 In marked contrast, release of the patient's platelet-derived FV/Va (7% of normal) following platelet

26 In contrast, increased platelet-derived FV/Va concentrations were observed with

27 l, thereby highlighting the critical role of platelet-derived FV/Va in ensuring hemostatic competence

28 Both plasma- and platelet-derived FXIIIa were susceptible to plasmin-medi

29 tion of matrix-associated GFs, TGF-beta, and platelet-derived GF to GF(-) or culture supernatants.

30 In particular, platelet-derived GPIbalpha proved critical for developme

31 The Platelet Derived Growth Factor (PDGF) family of ligands

32 Platelet derived growth factor (PDGF) plays a pivotal ro

33 ading frame, under the influence of a 1.5 kb platelet derived growth factor B (PDGFB) promoter.

34 Platelet Derived Growth Factor Receptor (PDGFR) signalin

35 Platelet derived growth factor receptor alpha (PDGFRalph

36 ent of known imatinib targets including Abl, platelet derived growth factor receptor beta (PDGFRbeta)

37 present study was to evaluate the levels of platelet derived growth factor-BB (PDGF-BB) in gingival

38 ession of the spliced XBP1 or treatment with platelet derived growth factor-BB up-regulated miR-150 e

39 tors such as tumor necrosis factor-alpha and platelet derived growth factor-BB were also found to inc

40 Many signaling pathways, including platelet- derived growth factor (PDGF)-AA/alphaalpha, ar

41 Platelet-derived growth factor (PDGF) acts through two c

42 Growth factors such as platelet-derived growth factor (PDGF) and the activation

43 Expression of both platelet-derived growth factor (PDGF) and vascular endot

44 e involved in the lipopolysaccharide-induced platelet-derived growth factor (PDGF) and Wnt signaling

45 10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, admini

46 agonist [WAY-200070 (WAY)] with TNF-alpha or platelet-derived growth factor (PDGF) followed by evalua

47 rowth factors, the most representative being platelet-derived growth factor (PDGF) isoforms (PDGF-AA,

48 ied KCE method to an experimental model of a platelet-derived growth factor (PDGF) protein and its DN

49 The platelet-derived growth factor (PDGF) receptor (PDGFR) f

50 While platelet-derived growth factor (PDGF) receptor alpha (PD

51 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors, has sin

52 roblast chemotaxis directed by a gradient of platelet-derived growth factor (PDGF) requires signaling

53 -of-function alterations leading to enhanced platelet-derived growth factor (PDGF) signaling are comm

54 We show here that the receptor for platelet-derived growth factor (PDGF) signaling recruits

55 Mechanistically, we show that the platelet-derived growth factor (PDGF) signalling pathway

56 optical biosensing modulation by insulin and platelet-derived growth factor (PDGF) using the Aptamer-

57 ng a small interfering RNA (siRNA) targeting platelet-derived growth factor (PDGF) was used to allevi

58 Platelet-derived growth factor (PDGF), a potent mitogen

59 clotted wound by a concentration gradient of platelet-derived growth factor (PDGF), together with oth

60 s transforming growth factor-beta (TGFbeta), platelet-derived growth factor (PDGF), WNT and hedgehog

61 In vitro platelet-derived growth factor (PDGF)- and tumor necrosi

62 Here, we show that platelet-derived growth factor (PDGF)-B/PDGF receptor be

63 Platelet-derived growth factor (PDGF)-BB belongs to a fa

64 EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1

65 rotid artery, and VSMCs were pretreated with platelet-derived growth factor (PDGF)-BB.

66 angiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-beta, and phosphat

67 We have identified platelet-derived growth factor (PDGF)-CC as a potent pro

68 e discovery of a novel ligand for PDGFRbeta, platelet-derived growth factor (PDGF)-DD, opened the pos

69 Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes

70 d quiescent mesenchymal cell activation in a platelet-derived growth factor (PDGF)-dependent manner.

71 Here, we present two novel platelet-derived growth factor (PDGF)-driven mouse model

72 ted knockdown of TRIM28 and TRIM27 inhibited platelet-derived growth factor (PDGF)-induced migration

73 In damaged retina of flies and mice, platelet-derived growth factor (PDGF)-like signaling ind

74 EC was uniformly inhibited by combined VEGF/platelet-derived growth factor (PDGF)/FGF receptor inhib

75 ular endothelial growth factor (VEGF) and 2) platelet-derived growth factor (PDGF-BB) in gingival cre

76 1 overexpression increases the expression of platelet-derived growth factor (PDGFB) in human pulmonar

77 sforming growth factor beta 1 (TGFbeta1) and platelet-derived growth factor (PDGFbetabeta) stimulatio

78 rbor an activating mutation in either KIT or platelet-derived growth factor A ( PDGFRA).

79 r receptor alpha (PDGFRalpha) and its ligand platelet-derived growth factor A (PDGF-A) are co-express

80 The membrane-bound receptor for platelet-derived growth factor A (PDGFRalpha) is crucial

81 s (angiopoietin 2; hepatocyte growth factor; platelet-derived growth factor AA and BB; placental grow

82 [TGF-beta1], epidermal growth factor [EGF], platelet-derived growth factor AB [PDGF-AB], and albumin

83 tor, vascular endothelial growth factor, and platelet-derived growth factor AB) before and after comp

84 line lung/liver SUVmax index correlated with platelet-derived growth factor AB.

85 These cells expressed platelet-derived growth factor alpha and high transcript

86 1, and transiently suppressed myofibroblast platelet-derived growth factor alpha differentiation mar

87 a similar level of TNF-alpha, TGF-beta1, and platelet-derived growth factor alpha genes, and a high l

88 Platelet-rich plasma (PRP) consists of platelet-derived growth factor and transforming growth f

89 Because platelet-derived growth factor B (PDGF-B) signaling has

90 , myogenesis regulating glycosidase (MYORG), platelet-derived growth factor B (PDGFB) and platelet-de

91 Platelet-derived growth factor B (PDGFB) plays a crucial

92 ar endothelial growth factor A (VEGF-A), and platelet-derived growth factor B chain (PDGF-BB), to sti

93 expression of vascular endothelial cadherin, platelet-derived growth factor B, S1P(1), and CCN1 (mole

94 r receptor in mice bearing RCAS/tv-a-induced platelet-derived growth factor B-overexpressing glioblas

95 modification of pericyte coverage involving platelet-derived growth factor B.

96 h, we demonstrate that two of these pathways-platelet-derived growth factor BB (PDGF BB) and neural p

97 study participants, the angiogenic cytokine platelet-derived growth factor BB glycoprotein correlate

98 Two weeks after AMI, increased PB platelet-derived growth factor BB glycoprotein was assoc

99 sely, PCSK6 overexpression increased PDGFBB (platelet-derived growth factor BB)-induced cell prolifer

100 henotype was hyperproliferative to serum and platelet-derived growth factor BB, and unresponsive to t

101 ombination of lentiviral vectors, expressing platelet-derived growth factor beta (PDGF-B), constituti

102 (VWF), glutathione peroxidase 3 (GPX3), and platelet-derived growth factor beta (PDGFB).

103 sessed relationships between tau and soluble platelet-derived growth factor beta (sPDGFRbeta), a CSF

104 nds to the transmembrane domain (TMD) of the platelet-derived growth factor beta receptor (PDGFbetaR)

105 ing smooth muscle alpha-actin (alphaSMA) and platelet-derived growth factor beta receptor (PDGFbetaR)

106 le amino acid substitutions can activate the platelet-derived growth factor beta receptor or the eryt

107 Soluble platelet-derived growth factor beta, an independent CSF

108 sions of fibrosis-related proteins including platelet-derived growth factor beta, fibronectin and col

109 nteract with the transmembrane domain of the platelet-derived growth factor beta-receptor and specifi

110 and cluster 4 (n=37; IL-8, IL-4, PDGF-beta [platelet-derived growth factor beta], IL-6, CCL11).

111 in, tissue inhibitor of metalloproteinase 1, platelet-derived growth factor c, transforming growth fa

112 odeling linked to maximal thrombospondin and platelet-derived growth factor D expression.

113 layed by transforming growth factor-beta and platelet-derived growth factor D in driving the recruitm

114 phages, T cells, and platelets and increased platelet-derived growth factor D, Pdgfrb, Itga2, and mat

115 We find that platelet-derived growth factor evokes transient oxidatio

116 ulture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on

117 razin-2(1H)-ones toward potent and effective platelet-derived growth factor receptor (PDGF-R) beta-in

118 ng fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and inte

119 It activates platelet-derived growth factor receptor (PDGFR) beta in

120 Platelet-derived growth factor receptor (PDGFR) senses e

121 YR mice had significantly reduced amounts of platelet-derived growth factor receptor (PDGFR), which i

122 Platelet-derived growth factor receptor (PDGFR)-alpha pl

123 isib also inhibited ALL proliferation in ABL/platelet-derived growth factor receptor (PDGFR)-mutant m

124 Anterograde transport mutants display low platelet-derived growth factor receptor (PDGFR)alpha lev

125 2), their coreceptor neuropilin1 (NRP1), and platelet-derived growth factor receptor (PDGFRalpha and

126 luded expected PI3K interactors, such as the platelet-derived growth factor receptor A (PDGFRA), as w

127 A fraction of Tppp3(+) cells expresses platelet-derived growth factor receptor alpha (Pdfgra).

128 GG), often in association with TP53 loss and platelet-derived growth factor receptor alpha (PDGFRA) a

129 rized by an oncogenic mutation in the KIT or platelet-derived growth factor receptor alpha (PDGFRA) g

130 Here, we show an essential role for platelet-derived growth factor receptor alpha (Pdgfra) i

131 ncogene, receptor tyrosine kinase (KIT), and platelet-derived growth factor receptor alpha (PDGFRA) i

132 -oncogene receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor alpha (PDGFRA) m

133 a CRISPR/Cas9 strategy identified guinea pig platelet-derived growth factor receptor alpha (PDGFRA) t

134 errations in FLT3, tyrosine kinase 2 (TYK2), platelet-derived growth factor receptor alpha (PDGFRA),

135 Here, we show that platelet-derived growth factor receptor alpha (PDGFRalph

136 Here we report that platelet-derived growth factor receptor alpha (PDGFRalph

137 Platelet-derived growth factor receptor alpha (PDGFRalph

138 many different signaling pathways, including platelet-derived growth factor receptor alpha (PDGFRalph

139 In this study, we isolated Platelet-derived growth factor receptor alpha (PDGFRalph

140 ellular origin of new myelin by fate mapping platelet-derived growth factor receptor alpha (PDGFRalph

141 l cells of Cajal (ICC), and cells expressing platelet-derived growth factor receptor alpha (PDGFRalph

142 a poor prognosis and exhibit an increase in platelet-derived growth factor receptor alpha (PDGFRalph

143 Platelet-derived growth factor receptor alpha (PDGFRalph

144 that TAg expression reduces the abundance of platelet-derived growth factor receptor alpha (PDGFRalph

145 VEGF enhanced the viability of platelet-derived growth factor receptor alpha (PDGFRalph

146 l cells of Cajal (ICC), and cells expressing platelet-derived growth factor receptor alpha (PDGFRalph

147 Here, we investigate the role of platelet-derived growth factor receptor alpha (PDGFRalph

148 tion of H3.3 K27M cooperated with activating platelet-derived growth factor receptor alpha (PDGFRalph

149 f cone-driven photoresponses, were bred with platelet-derived growth factor receptor alpha (Pdgfralph

150 ssed in primitive stromal cells that express platelet-derived growth factor receptor alpha and Sca-1

151 SMCs), interstitial cells of Cajal (ICC) and platelet-derived growth factor receptor alpha positive (

152 more, oncogenic RAB35 is sufficient to drive platelet-derived growth factor receptor alpha to LAMP2-p

153 IL1B stimulated subsets of platelet-derived growth factor receptor alpha(+) (PDGRFA

154 led alpha1 adrenoceptors (ARs) expression in platelet-derived growth factor receptor alpha(+) cells (

155 Populations of enteric neurons, ICC, and platelet-derived growth factor receptor alpha(+) cells w

156 differentiated alpha-smooth muscle actin(+)/platelet-derived growth factor receptor alpha(+)/CD44(+)

157 atrix by increasing nonmuscle myosin II- and platelet-derived growth factor receptor alpha-mediated c

158 press the mesenchymal stem cell (MSC) marker platelet-derived growth factor receptor alpha; hence, we

159 N, resulting in increased phosphorylation of platelet-derived growth factor receptor and activation o

160 (NOXs), and oxidized SHP2 co-localizes with platelet-derived growth factor receptor and NOX1/4.

161 ranscriptional response to Mucorales reveals platelet-derived growth factor receptor B (PDGFRB) signa

162 n profiling, which revealed up-regulation of platelet-derived growth factor receptor beta (Pdgfrb) an

163 platelet-derived growth factor B (PDGFB) and platelet-derived growth factor receptor beta (PDGFRB), a

164 Mesenchymal cells expressing platelet-derived growth factor receptor beta (PDGFRbeta)

165 Aberrant platelet-derived growth factor receptor beta (PDGFRbeta)

166 reased the catalytic loop phosphorylation of platelet-derived growth factor receptor beta (PDGFRbeta)

167 Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor beta and can cro

168 mooth muscle cells (ISMC) with expression of platelet-derived growth factor receptor beta and progres

169 [GRCh37/hg19]; c.1685A>G) change within the platelet-derived growth factor receptor beta gene (PDGFR

170 in 2 (IGFBP-2), nerve growth factor (b-NGF), platelet-derived growth factor receptor beta polypeptide

171 erved in a laser-induced model of CNV that a platelet-derived growth factor receptor beta positive (P

172 FDCs arise from perivascular platelet-derived growth factor receptor beta(+) precurso

173 gnificantly more NIK(+) ECs and perivascular platelet-derived growth factor receptor beta(+) preFDCs,

174 Glial fibrillary acid protein-Cre and platelet-derived growth factor receptor beta-Cre-mediate

175 l665Ala variant in PDGFRB, which encodes the platelet-derived growth factor receptor beta.

176 structure provides a first glimpse into how platelet-derived growth factor receptor ECD, upon ligand

177 he vascular endothelial growth factor (VEGF)/platelet-derived growth factor receptor inhibitor suniti

178 cular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitor, demon

179 ation and that it is selectively mediated by platelet-derived growth factor receptor signaling.

180 We recently discovered that the platelet-derived growth factor receptor(PDGFR)-beta sign

181 t epicardial-derived cells expressing PDGFR (platelet-derived growth factor receptor)-alpha were isol

182 tivation by a receptor activation loop (from platelet-derived growth factor receptor, a receptor tyro

183 ced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met.

184 ing Smad3, epidermal growth factor receptor, platelet-derived growth factor receptor, signal transduc

185 ell lines revealed co-activation of HER2 and platelet-derived growth factor receptor-alpha (PDGFRalph

186 opulation (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth factor receptor-alpha (PDGFRalph

187 Platelet-derived growth factor receptor-alpha (PDGFRalph

188 and flow sorted to isolate cells expressing platelet-derived growth factor receptor-alpha and exclud

189 ssion pattern, manifest in downregulation of platelet-derived growth factor receptor-alpha and recipr

190 rogenesis from precursor cells by inhibiting platelet-derived growth factor receptor-alpha cell endoc

191 to stabilize detrusor excitability involving platelet-derived growth factor receptor-alpha positive (

192 The presence and distributions of platelet-derived growth factor receptor-alpha(+) (PDGFRa

193 ild-type or constitutively activated PDGFRA (platelet-derived growth factor receptor-alpha) under con

194 cells coexpressing vimentin and PDGFRalpha (platelet-derived growth factor receptor-alpha), but gene

195 tyrosine kinases (RTKs) such as PDGFRalpha (platelet-derived growth factor receptor-alpha), which sh

196 Senescent cells were positive for platelet-derived growth factor receptor-alpha, vimentin,

197 alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive a

198 Connective tissue progenitor cells, platelet-derived growth factor receptor-alpha-positive c

199 y, 2) connective tissue progenitor cells, 3) platelet-derived growth factor receptor-alpha-positive c

200 nd dendritic spine formation through Rabex-5/platelet-derived growth factor receptor-beta (PDGFRbeta)

201 Platelet-derived growth factor receptor-beta (PDGFRbeta)

202 asculature followed by release of individual platelet-derived growth factor receptor-beta mural peric

203 iated capillary mural cell pericyte, soluble platelet-derived growth factor receptor-beta(8,18), and

204 a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine

205 agent targeting VEGF receptors 1, 2, and 3, platelet-derived growth factor receptor-like protein (PD

206 Our results identify the Snail-PTEN platelet-derived growth factor receptor/phosphatidylinos

207 structure of PDGFRbeta [a full-length human platelet-derived growth factor receptor], in complex wit

208 ne kinase activity of ABL1/BCR-ABL1 and KIT, platelet-derived growth factor receptors (PDGFRs), and t

209 Adipocyte progenitors (APs) express platelet-derived growth factor receptors (PDGFRs), PDGFR

210 Imatinib, a selective inhibitor of platelet-derived growth factor receptors, and anakinra,

211 -vascular endothelial growth factor and anti-platelet-derived growth factor signaling.

212 ively regulate G1 progression in response to platelet-derived growth factor stimulation.

213 y model, with positive correlation to PDGFB (platelet-derived growth factor subunit B) and MMP (matri

214 SMILR was also altered by interleukin-1alpha/platelet-derived growth factor treatment, and HAS2 expre

215 proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent prote

216 ophages, which then provide signals (such as platelet-derived growth factor) that drive beta-cell hyp

217 lated with IL (interleukin)-1alpha and PDGF (platelet-derived growth factor)-BB with SMILR knockdown

218 ristics when exposed to cholesterol or PDGF (platelet-derived growth factor).

219 d non-responders including stem cell factor, platelet-derived growth factor, and interleukin-15.

220 flammatory cytokines, invade Matrigel toward platelet-derived growth factor, and resist hypoxia-induc

221 Platelet-derived growth factor, estrogen, and serotonin

222 cedures, including enamel matrix derivative, platelet-derived growth factor, platelet concentrates, a

223 ine kinase ligands (epidermal growth factor, platelet-derived growth factor, vascular endothelial gro

224 Ectopic platelet-derived growth factor-AA (PDGF-AA) protein indu

225 rotrophic factor, fibroblast growth factors, platelet-derived growth factor-AA, vascular endothelial

226 e Boyden chamber and show that a gradient of platelet-derived growth factor-AB (PDGF-AB) expedites mi

227 sient treatment with AZA in combination with platelet-derived growth factor-AB converts primary somat

228 sed approach is shown here to work with both platelet-derived growth factor-BB (PDGF-BB) and vascular

229 lar endothelial growth factor-A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB) that were en

230 sforming growth factor-alpha (TGF-alpha) and platelet-derived growth factor-BB (PDGF-BB) were reduced

231 helial growth factor-A (VEGF-A) isoforms and platelet-derived growth factor-BB (PDGF-BB), mainly thro

232 the receptor tyrosine kinase (RTK) agonist, platelet-derived growth factor-BB (PDGF-BB)-induced p21C

233 rom the culture of fat with ROS or PGZ on i) platelet-derived growth factor-BB (PDGF-BB)-stimulated p

234 lar endothelial growth factor A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB).

235 (C-MEMS) was developed for the detection of platelet-derived growth factor-BB (PDGF-BB).

236 atrix derivative (EMD) and recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with beta-

237 tor-2, transforming growth factor-beta1, and platelet-derived growth factor-BB at 2 weeks compared wi

238 growth factor, interleukin 6, angiopoietin, platelet-derived growth factor-BB, placental growth fact

239 matory cytokines interferon gamma, IL-1, and platelet-derived growth factor-BB, which are not produce

240 rleukin-1alpha, placental growth factor, and platelet-derived growth factor-BB.

241 despite constituting a small fraction of the platelet-derived growth factor-beta (PDGFRbeta)(+) cell

242 nsforming growth factor-beta [TGF-beta], and platelet-derived growth factor-beta [PDGF-beta]) and blo

243 factor-D level, resulting in suppression of platelet-derived growth factor-beta activation and inhib

244 pe I collagen, matrix metalloprotease-1, and platelet-derived growth factor-beta.

245 In conclusion, our results suggest that platelet-derived growth factor-D is a target of itracona

246 ortantly, itraconazole significantly reduced platelet-derived growth factor-D level, resulting in sup

247 ein oxidation within cells, and suggest that platelet-derived growth factor-dependent "redoxosomes,"

248 es insight into the vascular architecture of platelet-derived growth factor-driven glioblastoma.

249 In vitro, RR6 inhibited platelet-derived growth factor-induced SMC proliferation

250 ascular endothelial growth factor (VEGF) and platelet-derived growth factor.

251 wing stimulation with interleukin-1alpha and platelet-derived growth factor.

252 CCN2 (connective tissue growth factor), and platelet-derived growth factor.

253 and PKM2 oxidation in cells stimulated with platelet-derived growth factor.

254 factor], sCD40L [soluble CD40 ligand], PDGF [platelet-derived growth factor], RANTES [regulated on ac

255 Platelet-derived growth factors (PDGF) have an ambiguous

256 Platelet-derived growth factors (PDGFs) and their recept

257 Thus, we establish platelet-derived HMGB1 as an important mediator of throm

258 atory diseases; however, the contribution of platelet-derived HMGB1 in thrombosis remains unexplored.

259 COMP) acts as a major endogenous plasma- and platelet-derived inhibitor of thrombin activity in vitro

260 In summary, a new neutrophil-activating platelet-derived lipid generated by COX-1 is presented t

261 sponse to donor-specific antibodies and that platelet-derived mediators may be markers of evolving al

262 Platelet-derived microparticles (PMPs) are associated wi

263 Platelet-derived microparticles (PMPs) are involved in h

264 rce microscopy (AFM) to quantify and qualify platelet-derived microparticles (PMPs), on the whole nan

265 positive material on fibres, suggesting that platelet-derived microparticles attach to fibrin.

266 Zeng et al. identified a mechanism by which platelet-derived microRNA-223 (miRNA-223) reverses VSMC

267 We identified direct RNA targets of platelet-derived miR-24 in tumor cells, which included m

268 Together, these results identify platelet-derived miRNA-223 as a potential therapeutic ta

269 Thus, platelet-derived miRNAs transfer in vivo to tumor cells

270 f patients with SCA and investigated whether platelet-derived molecules can induce phenotypic alterat

271 In contrast, the ontologically related platelet-derived MPs (PMPs) cannot be taken up by HSPCs

272 plasma dramatically increases the number of platelet-derived MPs, contaminates the extracellular miR

273 Platelet-derived MVs may be biomarkers of platelet activ

274 A massive release of platelet-derived MVs occurs during HIV infection.

275 More than 79% were platelet-derived MVs.

276 of PAI-1 demonstrate a major contribution by platelet-derived PAI-1 in the treatment of lenti-miR-30c

277 clots to fibrinolysis, in part by decreasing platelet-derived PAI-1.

278 Here, we show that platelet-derived PD-L1 regulates the growth of PD-L1 neg

279 ings establish a previously unknown role for platelet-derived PDGFB, whereby it promotes and maintain

280 Immunoblot assays for platelet-derived phosphorylated-eNOS (p-eNOS) and immuno

281 length found in platelets (60-100 mer), and platelet-derived polyP significantly augment the plasmin

282 XIa-dependent factor IX (FIX) activation, or platelet-derived polyP, respectively.

283 bute to thrombosis in animal models, whereas platelet-derived polyphosphate (polyP) may potentiate co

284 contain polyphosphate, and the secretion of platelet-derived polyphosphate has been associated with

285 tool to improve the therapeutic efficacy of platelet-derived proteins for wound healing.

286 Platelet-derived proteins incorporated into the coacerva

287 further promoting the luminal deposition of platelet-derived regulated on activation normal T cell e

288 solid tumors in humans and mice and transfer platelet-derived RNA, including miRNAs, to tumor cells i

289 Platelet-derived serotonin induced neutrophil degranulat

290 In vitro, platelet-derived soluble CD84 enhanced motility of wild-

291 that FXIa neutralized both endothelium- and platelet-derived TFPI by cleaving the protein between th

292 Finally, we demonstrate that platelet-derived TSP1 modulates arterial thrombosis in v

293 Thus, platelet-derived TXA2 orchestrates the generation of a f

294 Finally, platelet-derived-TxA2 elicits a full neutrophil response

295 he naive FVIII null hemophilia A (HA) mouse, platelet-derived VIII prevents both a primary and memory

296 henne et al present data showing the role of platelet-derived von Willebrand factor (VWF) in mediatin

297 created mice with either endothelial VWF or platelet-derived VWF and examined each phenotype for ble

298 These data suggest that whereas platelet-derived VWF does not play a crucial role in hem

299 Mice with only platelet-derived VWF had defective hemostasis and defect

300 These data suggest that platelet-derived VWF plays a specific role in stroke pat

301 r intriguing findings were that mice lacking platelet-derived VWF, but with adequate endothelial VWF